Condition
Undifferentiated Pleomorphic Sarcoma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Undifferentiated Pleomorphic Sarcoma clinical trials that are recruiting, at sites in 6 countries (most in France (2), United States (1), China (1)). By phase: Phase 2 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 6Countries
Newest Undifferentiated Pleomorphic Sarcoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| MASCT-I plus doxorubicin and ifosfamide as first-line treatment for advanced soft tissue sarcoma | Phase 2 | Guangzhou | Recruiting | Feb 26, 2024 |
| Combining propranolol and pembrolizumab for advanced soft tissue sarcoma | Phase 2 | Aarhus and 3 other locations | Recruiting | Jul 27, 2023 |
| Combining pembrolizumab and cabozantinib for advanced sarcomas | Phase 2 | Bordeaux and 9 other locations | Recruiting | Jan 10, 2022 |
| Combining pembrolizumab with local chemotherapy for sarcoma treatment in limbs | Phase 2 | Basking Ridge, New Jersey and 6 other locations | Recruiting | Apr 3, 2020 |
| Using Regorafenib to Maintain Treatment Benefits After Initial Therapy for Bone Sarcomas | — | Besançon and 15 other locations | Recruiting | Aug 13, 2019 |
All recruiting trials (5)
-
MASCT-I plus doxorubicin and ifosfamide as first-line treatment for advanced soft tissue sarcoma
This trial will test whether adding MASCT-I to standard chemotherapy (doxorubicin and ifosfamide) helps adults with advanced soft tissue sarcoma respond better or live longer.
-
Combining propranolol and pembrolizumab for advanced soft tissue sarcoma
This study is testing a new combination of two medications, propranolol and pembrolizumab, to see if it can help people with advanced angiosarcoma or undifferentiated pleomorphic sarcoma live longer and feel better.
-
Combining pembrolizumab and cabozantinib for advanced sarcomas
This study is testing if combining two treatments, pembrolizumab and cabozantinib, can help people with advanced types of sarcoma feel better and improve their condition.
-
Combining pembrolizumab with local chemotherapy for sarcoma treatment in limbs
This study is testing if combining an immunotherapy drug with local chemotherapy can help people with advanced sarcoma in their limbs live longer without their disease getting worse.
-
Using Regorafenib to Maintain Treatment Benefits After Initial Therapy for Bone Sarcomas
This study is testing if the drug regorafenib can help people with bone sarcomas stay cancer-free longer after their initial treatment.
Related topics
Quick answers
How many Undifferentiated Pleomorphic Sarcoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in France (2 trials), United States (1 trial), China (1 trial), Denmark (1 trial), Norway (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.